연구용
제품 번호: S7070
| 관련 타겟 | HDAC JAK BET Histone Methyltransferase PKC PARP HIF PRMT EZH2 AMPK |
|---|---|
| 기타 Histone Demethylase 억제제 | SP2509 JIB-04 GSK-LSD1 2HCl Iadademstat (ORY-1001) Dihydrochloride CPI-455 HCl OG-L002 IOX1 GSK J1 ML324 CP2 |
| 세포주 | 분석 유형 | 농도 | 배양 시간 | 제형 | 활성 설명 | PMID |
|---|---|---|---|---|---|---|
| CUTLL1 | Growth inhibitory assay | 2 μM | DMSO | affects cell growth | 25132549 | |
| CUTLL1 | Apoptosis assay | 2 μM | DMSO | induces apoptosis | 25132549 | |
| CUTLL1 | Function assay | 2 μM | DMSO | induces cell cycle arrest | 25132549 | |
| CUTLL1 | Kinase assay | 6 μM | DMSO | leads to increased H3K27me3 | 25132549 | |
| SF7761 | Kinase assay | 6 μM | DMSO | increases K27 methylation | 25401693 | |
| SF8628 | Kinase assay | 6 μM | DMSO | increases K28 methylation | 25401693 | |
| H3.3 | Kinase assay | 6 μM | DMSO | increases K29 methylation | 25401693 | |
| SF9012 | Kinase assay | 6 μM | DMSO | increases K30 methylation | 25401693 | |
| SF9402 | Kinase assay | 6 μM | DMSO | increases K31 methylation | 25401693 | |
| SF9427 | Kinase assay | 6 μM | DMSO | increases K32 methylation | 25401693 | |
| human astrocytes | Kinase assay | 6 μM | DMSO | increases K33 methylation | 25401693 | |
| SF7761 | Growth inhibitory assay | 6 μM | DMSO | inhibits K27M glioma cell growth | 25401693 | |
| SF8628 | Growth inhibitory assay | 6 μM | DMSO | inhibits K28M glioma cell growth | 25401693 | |
| H3.3 | Growth inhibitory assay | 6 μM | DMSO | inhibits K29M glioma cell growth | 25401693 | |
| SF9012 | Growth inhibitory assay | 6 μM | DMSO | inhibits K30M glioma cell growth | 25401693 | |
| SF9402 | Growth inhibitory assay | 6 μM | DMSO | inhibits K31M glioma cell growth | 25401693 | |
| SF9427 | Growth inhibitory assay | 6 μM | DMSO | inhibits K32M glioma cell growth | 25401693 | |
| human astrocytes | Growth inhibitory assay | 6 μM | DMSO | inhibits K33M glioma cell growth | 25401693 | |
| TG neurons | Function assay | 50 μM | DMSO | inhibits HSV-1 reactivation from sensory neurons | 25552720 | |
| Th17 | Function assay | 80 nM | DMSO | inhibits cell differentiation | 25840993 | |
| β-cells | Function assay | 20 μM | DMSO | blunts IFNγ, Il-1β, and TNFα-induced chemokine gene expression | 26505193 | |
| β-cells | Function assay | 20 μM | DMSO | induces β-cell dysfunction | 26505193 | |
| ESCs | Function assay | 1.8 µM | DMSO | induces DNA damage along with activation of the DNA damage response | 26759175 | |
| Raw 264.7 | Function assay | 0.8192 µM | DMSO | inhibits TNF-α production | 26776360 | |
| MCF7 | Function assay | 1 to 10 uM | 30 hrs | Inhibition of KDM5A in human MCF7 cells assessed as effect on H3K4me3 methylation levels at 1 to 10 uM after 30 hrs by Western blot analysis | 30392349 | |
| MCF7 | Function assay | 1 to 10 uM | 30 hrs | Inhibition of KDM5A in human MCF7 cells assessed as effect on H3K27me3 methylation levels at 1 to 10 uM after 30 hrs by Western blot analysis | 30392349 | |
| RAW264.7 | 0.82 uM | 24 hrs | Inhibition of LPS-induced TNFalpha production in mouse RAW264.7 cells 0.82 uM after 24 hrs by ELISA | 26776360 | ||
| RAW264.7 | 24 hrs | Inhibition of LPS-induced TNFalpha production in mouse RAW264.7 cells after 24 hrs by ELISA | 26776360 | |||
| 클릭하여 더 많은 세포주 실험 데이터 보기 | ||||||
| 분자량 | 453.96 | 화학식 | C24H27N5O2.HCl |
보관 (수령일로부터) | |
|---|---|---|---|---|---|
| CAS 번호 | 1797983-09-5 | SDF 다운로드 | 원액 보관 |
|
|
|
In vitro |
DMSO
: 91 mg/mL
(200.45 mM)
Ethanol : 91 mg/mL Water : 10 mg/mL |
|
In vivo |
|||||
1단계: 아래 정보 입력 (권장: 실험 중 손실을 고려하여 추가 동물 포함)
2단계: 생체 내 제형 입력 (이것은 계산기일 뿐 제형이 아닙니다. 용해도 섹션에 생체 내 제형이 없는 경우 먼저 당사에 문의하십시오.)
계산 결과:
작업 농도: mg/ml;
DMSO 원액 준비 방법: mg 약물 사전 용해 μL DMSO ( 원액 농도 mg/mL, 농도가 해당 약물 배치의 DMSO 용해도를 초과하는 경우 먼저 당사에 문의하십시오. )
생체 내 제형 준비 방법: 취하다 μL DMSO 원액, 다음 추가μL PEG300, 혼합하고 투명하게 한 다음 추가μL Tween 80, 혼합하고 투명하게 한 다음 추가 μL ddH2O, 혼합하고 투명하게 합니다.
생체 내 제형 준비 방법: 취하다 μL DMSO 원액, 다음 추가 μL 옥수수 기름, 혼합하고 투명하게 합니다.
참고: 1. 다음 용매를 추가하기 전에 액체가 투명한지 확인하십시오.
2. 용매를 순서대로 추가해야 합니다. 다음 용매를 추가하기 전에 이전 추가에서 얻은 용액이 투명한 용액인지 확인해야 합니다. 와동, 초음파 또는 뜨거운 물 중탕과 같은 물리적 방법을 사용하여 용해를 도울 수 있습니다.
| Targets/IC50/Ki |
JMJD3
(Cell-free assay) 60 nM
|
|---|---|
| 시험관 내(In vitro) |
GSK J4 HCl is an ethyl ester derivative of the JMJD3 selective histone demethylase inhibitor GSK-J1 with an IC50 value greater than 50 μM in vitro. This compound is used to probe the consequences of demethylation of H3K27me3. In human primary macrophages, this chemical inhibits the lipopolysaccharide-induced production of cytokines, including pro-inflammatory tumour necrosis factor (TNF). In addition, it prevents the lipopolysaccharide-induced loss of H3K27me3 associated with the TNF transcription start sites and blocked the recruitment of RNA polymerase II. |
| 키나아제 분석 |
Histone Demethylase AlphaScreen
|
|
Inhibition of histone demethylases is assessed using the histone demethylase AlphaScreen assay (Amplified Luminescence Proximity Homogenous Assay). This assay uses a biotinylated peptide substrate and relies on detection of the product methyl mark using a specific antibody coupled to protein-A acceptor beads and a Steptavidin donor bead to capture the peptide. In brief, recombinant demethylase enzymes are incubated in the presence of Fe2+ in the form of Ferrous Ammonium Sulphate (FAS), -ketoglutarate (KG) and biotinylated peptide substrate. L-Ascorbic Acid is included to provide a reducing environment and prevent oxidation of Fe2+. After incubation with peptide substrate the presence of the product is detected using AlphaScreen technology. The demethylase AlphaScreen assays are performed in 384-well plate format using white proxiplates. All steps are carried out in assay buffer (50 mM HEPES pH 7.5, 0.1% (w/v) BSA and 0.01 % (v/v) Tween-20). FAS is dissolved fresh each day in 20 mM HCl to a concentration of 400 mM and diluted to 1.0 mM in deionized water. All other components are dissolved fresh each day in deionized water. For IC50 determinations 5 μL of assay buffer containing demethylase enzyme is transferred to wells of a 384-well proxiplate. Titrations of this compound (0.1 μL) are transferred to each well and the enzymes allowed to pre-incubate for 15 minutes with this chemical (final concentration of DMSO is 1%). The enzyme reaction is initiated by addition of 5 μL of a substrate mix consisting of α-KG, FAS, L-Ascorbic Acid and biotinylated peptide substrate and the reaction incubated for the indicated time at room temperature. The enzyme reaction is stopped after the indicated time by addinton of 5 μL of EDTA (7.5 mM final concentration in assay buffer). Streptavidin Donor beads (0.08 mg/ml) and Protein-A conjugated acceptor beads (0.08 mg/ml) are pre-incubated for 1 hour with an antibody to the product methyl mark and the presence of biotin-H3-product is detected by addition of 5 μL of the preincubated AlphaScreen beads (final concentrations of 0.02 mg/ml with respect to acceptor and donor beads). Detection is allowed to proceed for 1 hour at room temperature and the assay plates read in a BMG Labtech Pherastar FS plate reader. Data are normalized to the no enzyme control and the IC50 determined from the nonlinear regression curve fit using GraphPad Prism 5.
|
|
| 생체 내(In vivo) |
GSK-J4 hydrochloride is a potent dual inhibitor of H3K27me3/me2-demethylases JMJD3/KDM6B and UTX/KDM6A. It inhibits LPS-induced TNF-α production in human primary macrophages. This compound is a cell permeable prodrug of GSK-J1. |
참조 |
|